Literature DB >> 8608638

Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium.

E Peen1, T Sundqvist, T Skogh.   

Abstract

Human polymorphonuclear neutrophil leucocytes (PMNL) prestimulated with the formylated tripeptide f-Met-Leu-Phe (fMLP) were activated to an immediate chemiluminescence (CL) response by polyclonal rabbit antibodies against human lactoferrin (Lf). This activation, indicating the formation of reactive oxygen species, was induced by intact IgG antibodies but could not be brought about by F(ab')2 fragments. Human Lf was also shown to adhere to the surface of cultured bovine aorta endothelial cells (BEC). When Lf-coated BEC grown on microcarrier beads were reacted with anti-Lf antibodies, an immediate CL response was achieved also with nonprimed PMNL. Here, too, the reaction required intact IgG antibodies. Also, patient sera containing anti-Lf autoantibodies of IgG class were shown to activate fMLP-treated PMNL. The same effect was obtained (in a dose-dependent manner) with the gammaglobulin fraction from anti-Lf-positive serum. Further, anti-Lf-antibody-positive patient sera incubated with Lf-coated BEC beads were also able to activate non-stimulated PMNL to a chemiluminescence response. The results are discussed in relation to possible mechanisms of cell/tissue damage induced by anti-neutrophil cytoplasmic antibodies (ANCA).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608638      PMCID: PMC2200365          DOI: 10.1111/j.1365-2249.1996.tb08294.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Modulation of polymorphonuclear leukocyte chemiluminescent response to the chemoattractant f-Met-Leu-Phe.

Authors:  C Dahlgren; K E Magnusson; O Stendahl; T Sundqvist
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

2.  Uptake of lactoferrin by the liver. II. Endocytosis by sinusoidal cells.

Authors:  P J Courtoy; N Moguilevsky; L A Retegui; C E Castracane; P L Masson
Journal:  Lab Invest       Date:  1984-03       Impact factor: 5.662

3.  Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold.

Authors:  E Cramer; K B Pryzwansky; J L Villeval; U Testa; J Breton-Gorius
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

4.  Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.

Authors:  A J Porges; P B Redecha; W T Kimberly; E Csernok; W L Gross; R P Kimberly
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

5.  Effects of anti-human neutrophil antibodies in vitro. Quantitative studies.

Authors:  L A Boxer; T P Stossel
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

6.  Neutropenia induced by systemic infusion of lactoferrin.

Authors:  L A Boxer; B Björkstén; J Björk; H H Yang; J M Allen; R L Baehner
Journal:  J Lab Clin Med       Date:  1982-06

7.  Plasma lactoferrin reflects granulocyte activation in vivo.

Authors:  J A Lash; T D Coates; J Lafuze; R L Baehner; L A Boxer
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

8.  Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness.

Authors:  R Oseas; H H Yang; R L Baehner; L A Boxer
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

9.  Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process.

Authors:  A H Mulder; P Heeringa; E Brouwer; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

10.  The involvement of lactoferrin in the hyposideremia of acute inflammation.

Authors:  J L Van Snick; P L Masson; J F Heremans
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Comparative effects of antilactoferrin antibodies and tumor necrosis factor on neutrophil adherence to matrix proteins.

Authors:  B Zweiman; C von Allmen
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.

Authors:  Irena Manolova; Maria Dantcheva
Journal:  Rheumatol Int       Date:  2004-11-11       Impact factor: 2.631

4.  The Presence of Anti-Lactoferrin Antibodies in a Subgroup of Eosinophilic Granulomatosis with Polyangiitis Patients and Their Possible Contribution to Enhancement of Neutrophil Extracellular Trap Formation.

Authors:  Haruki Shida; Daigo Nakazawa; Yu Tateyama; Arina Miyoshi; Yoshihiro Kusunoki; Fumihiko Hattanda; Sakiko Masuda; Utano Tomaru; Tamihiro Kawakami; Tatsuya Atsumi; Akihiro Ishizu
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

5.  A Novel Murine Anti-Lactoferrin Monoclonal Antibody Activates Human Polymorphonuclear Leukocytes through Membrane-Bound Lactoferrin and TLR4.

Authors:  Xiao-Min Hu; Yan-Rui Xu; Ru Yan; Shu-Liang Sun; Hong-Liang Dong; Jun Wang; Xiao-Ming Gao
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.